Drug Shortage Report for APO-ACETAMINOPHEN

Last updated on 2025-01-03

Report ID 240635
Drug Identification Number 00544981
Brand name APO-ACETAMINOPHEN
Common or Proper name ACETAMINOPHEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ACETAMINOPHEN
Strength(s) 325MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 U/D
ATC code N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-16
Estimated end date 2025-01-17
Actual end date 2025-01-02
Shortage status Resolved
Updated date 2025-01-03
Company comments 1000 BTL available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-01-03 French Compare
v11 2025-01-03 English Compare
v10 2024-12-19 French Compare
v9 2024-12-19 English Compare
v8 2024-12-04 French Compare
v7 2024-12-04 English Compare
v6 2024-11-14 French Compare
v5 2024-11-14 English Compare
v4 2024-11-07 French Compare
v3 2024-11-07 English Compare
v2 2024-10-18 French Compare
v1 2024-10-18 English Compare

Showing 1 to 12 of 12